31-45 of 813
Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstractsSwitching to Risdiplam Maintains Motor Gains in SMA Patients
Ryan Quigley
Who’s Missing from Multiple Sclerosis Research?
NeuroFrontiersWho’s Missing from Multiple Sclerosis Research?
Ashley Baker, MSN, PMHNP
Ruth Ann Marrie, MD, PhD
GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
NeuroFrontiersGFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
NeuroFrontiersCK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
Multiple Sclerosis Without Borders: Taking a Global View
NeuroFrontiersMultiple Sclerosis Without Borders: Taking a Global View
Andrew Wilner, MD, FACP, FAAN
Victor Rivera, MD
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
NeuroFrontiersMultiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Raphael Schneider, MD, PhD, FRCPC, CIP
- advertisement
Understanding Accelerated Biological Aging in Pediatric MS
NeuroFrontiersUnderstanding Accelerated Biological Aging in Pediatric MS
Jennifer Yang, MD
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
NeuroFrontiersAdvancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
Adil Harroud, MD
Dylan Hamitouche
Ryan Quigley
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Global Neurology AcademyOCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Mike Sharma, MD, MSc, FRCPC
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Global Neurology AcademyBeyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Ashkan Shoamanesh, MD
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
On the Frontlines of SchizophreniaDelivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Alexandria May, PharmD, BCPS
Apurva Bhatt, MD
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
NeuroFrontiersVitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
- advertisement
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
NeuroFrontiersIron Deposition and Cognitive Fatigue in Multiple Sclerosis
Evaluating Structured Interventions for Cognitive Support in MS
AudioAbstractsEvaluating Structured Interventions for Cognitive Support in MS
Hallie Blevins, PhD
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiersOptimizing Vitamin D Supplementation in MS Care
